Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

USA - NYSE:CXT - US2244411052 - Common Stock

58.59 USD
-1.58 (-2.63%)
Last: 11/14/2025, 8:04:00 PM
58.59 USD
0 (0%)
After Hours: 11/14/2025, 8:04:00 PM
Fundamental Rating

5

Overall CXT gets a fundamental rating of 5 out of 10. We evaluated CXT against 123 industry peers in the Electronic Equipment, Instruments & Components industry. CXT scores excellent on profitability, but there are concerns on its financial health. CXT may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CXT was profitable.
In the past year CXT had a positive cash flow from operations.
Each year in the past 5 years CXT has been profitable.
CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 5.30%, CXT is doing good in the industry, outperforming 73.17% of the companies in the same industry.
CXT has a better Return On Equity (12.74%) than 80.49% of its industry peers.
CXT has a Return On Invested Capital of 8.69%. This is in the better half of the industry: CXT outperforms 77.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 9.58%.
The 3 year average ROIC (13.27%) for CXT is well above the current ROIC(8.69%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.69%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

The Profit Margin of CXT (9.80%) is better than 80.49% of its industry peers.
CXT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 17.59%, CXT belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
CXT's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 43.20%, CXT is doing good in the industry, outperforming 74.80% of the companies in the same industry.
CXT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CXT is still creating some value.
CXT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CXT has an Altman-Z score of 2.27. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
CXT has a worse Altman-Z score (2.27) than 67.48% of its industry peers.
CXT has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CXT would need 6.27 years to pay back of all of its debts.
CXT has a Debt to FCF ratio (6.27) which is comparable to the rest of the industry.
CXT has a Debt/Equity ratio of 0.89. This is a neutral value indicating CXT is somewhat dependend on debt financing.
CXT has a Debt to Equity ratio of 0.89. This is amonst the worse of the industry: CXT underperforms 87.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.27
ROIC/WACC0.95
WACC9.12%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.26 indicates that CXT should not have too much problems paying its short term obligations.
CXT has a Current ratio of 1.26. This is amonst the worse of the industry: CXT underperforms 82.93% of its industry peers.
CXT has a Quick Ratio of 1.26. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
CXT has a Quick ratio of 0.94. This is amonst the worse of the industry: CXT underperforms 81.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CXT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.72%.
The Earnings Per Share has been decreasing by -6.61% on average over the past years.
CXT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
The Revenue has been growing slightly by 3.39% on average over the past years.
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%

3.2 Future

Based on estimates for the next years, CXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.90% on average per year.
Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y-2.78%
EPS Next 2Y6.83%
EPS Next 3Y8.9%
EPS Next 5YN/A
Revenue Next Year7.56%
Revenue Next 2Y7.6%
Revenue Next 3Y7.74%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.68, the valuation of CXT can be described as correct.
86.99% of the companies in the same industry are more expensive than CXT, based on the Price/Earnings ratio.
CXT is valuated rather cheaply when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.02, CXT is valued correctly.
Based on the Price/Forward Earnings ratio, CXT is valued cheaply inside the industry as 91.06% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.59. CXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.68
Fwd PE 12.02
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 83.74% of the companies listed in the same industry.
81.30% of the companies in the same industry are more expensive than CXT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.49
EV/EBITDA 10.6
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.83%
EPS Next 3Y8.9%

6

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.13%. Purely for dividend investing, there may be better candidates out there.
CXT's Dividend Yield is rather good when compared to the industry average which is at 2.17. CXT pays more dividend than 86.99% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, CXT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

24.82% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.82%
EPS Next 2Y6.83%
EPS Next 3Y8.9%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (11/14/2025, 8:04:00 PM)

After market: 58.59 0 (0%)

58.59

-1.58 (-2.63%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners110.42%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change0.41%
Market Cap3.36B
Revenue(TTM)1.58B
Net Income(TTM)154.70M
Analysts81.82
Price Target95.15 (62.4%)
Short Float %13.19%
Short Ratio14.86
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-28 2025-11-28 (0.17)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.49%
PT rev (3m)4.15%
EPS NQ rev (1m)-4%
EPS NQ rev (3m)-3.88%
EPS NY rev (1m)0.04%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)1.06%
Revenue NQ rev (3m)-2.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 14.68
Fwd PE 12.02
P/S 2.13
P/FCF 19.49
P/OCF 15.52
P/B 2.77
P/tB N/A
EV/EBITDA 10.6
EPS(TTM)3.99
EY6.81%
EPS(NY)4.87
Fwd EY8.32%
FCF(TTM)3.01
FCFY5.13%
OCF(TTM)3.78
OCFY6.44%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number43.57
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.69%
ROICexc 9.36%
ROICexgc 34.76%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexgc growth 3Y39.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.27
F-Score3
WACC9.12%
ROIC/WACC0.95
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
EPS Next Y-2.78%
EPS Next 2Y6.83%
EPS Next 3Y8.9%
EPS Next 5YN/A
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%
Revenue Next Year7.56%
Revenue Next 2Y7.6%
Revenue Next 3Y7.74%
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year18.55%
EBIT Next 3Y14.58%
EBIT Next 5YN/A
FCF growth 1Y-55.34%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-48.89%
OCF growth 3Y-8.23%
OCF growth 5YN/A

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


What is the valuation status for CXT stock?

ChartMill assigns a valuation rating of 6 / 10 to CRANE NXT CO (CXT). This can be considered as Fairly Valued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for CXT stock?

The Price/Earnings (PE) ratio for CRANE NXT CO (CXT) is 14.68 and the Price/Book (PB) ratio is 2.77.


What is the expected EPS growth for CRANE NXT CO (CXT) stock?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to decline by -2.78% in the next year.